
Connecticut-based firm Biohaven has said its migraine drug rimegepant showed superiority over placebo in a Phase 3 clinical trial. The …

Paul Kavanagh, partner at law firm Dechert, explores the relationship between GDPR and CTR, and its potential impact on the …

A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at …

Louis Goss talks to Harvard Medical School placebo expert Dr Ted Kaptchuk in asking what the placebo effect means for …

The FDA has placed a partial clinical hold on studies of multiple myeloma treatment Venclexta/Venclyxto (venetoclax) following a number of …

Celgene’s Abraxane, in combination gemcitabine, has failed to meet its primary endpoint in a pivotal Phase 3 trial of patients …

The Cambridgeshire and Peterborough NHS Foundation Trust’s Windsor Research Unit is offering patients the chance to participate in clinical trials …

Clinical trials have led to nearly 5,000 deaths in India since 2005, while just a fraction of those affected have …

American multinational Amgen has teamed up with the Lazarex Cancer Foundation in support of an initiative aimed at increasing access …
HORWICH, BOLTON Dec1 2018: Woodley Equipment Company Inc, a leading global supplier of rental equipment for use in Clinical Trials …

Pfizer’s palbociclib is the most commonly used breast cancer drug in clinical trials, according to analytics firm GlobalData. The drug, …

A new study may help to significantly reduce the number of dogs that are used in clinical trials, according to …

As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …

The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …